UCLA Portal

	About Us
	Education
	Medical Student Admissions
	Research
	Departments
	Faculty Search
	Administration
	Resources for Faculty
	Resources for Residents
	Resources for Medical Students
	Graduate Student Education
	Alumni
	Community Outreach
	Clinical Trials

Sanaz Memarzadeh, M.D., Ph.D.

Affiliations

Assistant Professor, Obstetrics and Gynecology

Education:
Medical Degree:	M.D., University of Pittsburgh School of Medicine, 1996
Degree:	Ph.D., University of California, Los Angeles, 2008

Certifications:
Medical Board Certification:	Gynecologic Oncology, 2008 Obstetrics & Gynecology, American Board of Obstetrics and Gynecology, 2005

Education:
Fellowship:	Gynecologic Oncology, UCLA School of Medicine, 2003
Residency:	Obstetrics & Gynecology, UCLA School of Medicine, 2000
Internship:	Obstetrics & Gynecology, UCLA School of Medicine, 1997

Contact Information:

Mailing Address:	Suite 220 Box 6928 Los Angeles, CA 90095 UNITED STATES

Direct Contact Information:

Office Phone Number:	310-206-8915 Academic line 310-206-8972 Patient scheduling
Work Phone Number:	310 794-7274 Patient Scheduling 310 794-9093 Obgyn Oncology Nurse

Additional Information:

Dr. Sanaz Memarzadeh is a board certified gynecologic oncologist. She specializes in the prevention, diagnosis and treatment of all gynecologic pre-invasive and invasive diseases. She has completed her residency at the UCLA medical Center. After the conclusion of her formal residency, she completed a three year fellowship training in gynecologic oncology at the UCLA Medical Center. This fellowship is designed to meet the subspecialty requirements of the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and functions in concert with the Gynecologic Oncology Divisions at Cedars-Sinai and Kaiser Permanente. This fellowship has provided her with advanced surgical training for treatment of gynecologic cancers in addition to training in administration of chemotherapy and care for cancer patients. Following her fellowship, Dr. Memarzadeh completed a Ph.D. in the department of Molecular Biology at UCLA. Dr. Memarzadeh performs basic science research at UCLA focusing on molecular pathways that lead to the development of gynecologic cancers. She has won multiple awards including the Reproductive Scientist Developmental Grant, the Ovarian Cancer Research Foundation Grant and a Gynecologic Cancer Foundation award. Dr. Memarzadeh has authored many published articles in respected journals and textbook chapters. Dr. Memarzadeh currently maintains staff and operating room privileges at UCLA Westwood. She is accepting new patients seeking care in all aspects of gynecologic cancer or pre-cancerous diseases.

Publications:

Memarzadeh Sanaz, Xin Li, Mulholland David J, Mansukhani Alka, Wu Hong, Teitell Michael A, Witte Owen N Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.. Cancer Cell. 2007; 12(6): 572-85.

Memarzadeh S, Lee S B, Berek J S, Farias-Eisner R CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2004; 13(2): 120-4.

Memarzadeh S, Holschneider C H, Bristow R E, Jones N L, Fu Y S, Karlan B Y, Berek J S, Farias-Eisner R FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2004; 12(5): 454-8.

Memarzadeh Sanaz, Natarajan Sathima, Dandade Dipika P, Ostrzega Nora, Saber Peter A, Busuttil Ashley, Lentz Scott E, Berek Jonathan S Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.. Cancer Cell. 2003; 102(3): 612-9.

Ide Hisamitsu, Seligson David B, Memarzadeh Sanaz, Xin Li, Horvath Steve, Dubey Purnima, Flick Maryann B, Kacinski Barry M, Palotie Aarno, Witte Owen N Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(22): 14404-9.

Memarzadeh Sanaz, Kozak Katherine R, Chang Lisbeth, Natarajan Sathima, Shintaku Peter, Reddy Srinivasa T, Farias-Eisner Robin, Memarzedeh Sanaz Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.. Proc. Natl. Acad. Sci. U.S.A.. 2002; 99(16): 10647-52.

Memarzadeh S, Berek J S Advances in the management of epithelial ovarian cancer.. The Journal of reproductive medicine. 2001; 46(7): 621-9; discussion 629-30.

Behboo R, Carroll P B, Memarzadeh S, Zeevi A, Conrad B, Rastellini C, Rao A S, Ricordi C Improved long-term culture of functional human islets in serum-free medium.. Transplantation proceedings. 1994; 26(6): 3301.


UCLA Health Sciences	UCLA	Terms & Conditions	Privacy Practices	Disability Resources	© UC Regents